Company Filing History:
Years Active: 2021-2023
Title: Innovations of Romel Menacho Melgar
Introduction
Romel Menacho Melgar is an accomplished inventor based in Durham, NC (US). He has made significant contributions to the field of biotechnology, particularly in the area of genetically modified microorganisms. With a total of 2 patents, his work has the potential to impact various applications in protein engineering.
Latest Patents
Romel's latest patents focus on in vivo protein N-acylation. These patents describe a genetically modified microorganism that includes a first gene encoding an acyl transferase and a second gene encoding a peptide or protein. One or both of these genes may be heterologous. The genetically modified microorganism also features a modified acyl-CoA biosynthetic pathway, which is configured for inducible biosynthesis of acyl-CoA and over-accumulation of acyl-CoA. This microorganism can effectively cause acylation of the peptide or protein by the acyl transferase using the acyl-CoA, resulting in a N-acylated peptide or protein product.
Career Highlights
Romel Menacho Melgar is affiliated with Duke University, where he conducts his research and development activities. His innovative work in biotechnology has garnered attention and recognition within the scientific community.
Collaborations
Romel collaborates with Michael David Lynch, contributing to advancements in their shared field of expertise.
Conclusion
Romel Menacho Melgar's contributions to biotechnology through his patents and research at Duke University highlight his role as a significant inventor in the field. His work on genetically modified microorganisms showcases the potential for innovative solutions in protein engineering.